Johnson Matthey PLC (LON:JMAT – Get Free Report) has been given an average recommendation of “Moderate Buy” by the six research firms that are presently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is GBX 2,283.33.
Several research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 2,400 price objective on shares of Johnson Matthey in a research note on Monday, July 6th. UBS Group restated a “neutral” rating and set a GBX 2,200 price objective on shares of Johnson Matthey in a report on Friday, May 22nd. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 2,330 price objective on shares of Johnson Matthey in a research note on Tuesday, August 4th. Finally, Berenberg Bank lifted their price target on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research note on Monday, June 1st.
Read Our Latest Report on JMAT
Johnson Matthey Stock Performance
Insider Buying and Selling at Johnson Matthey
In other Johnson Matthey news, insider Alastair Judge bought 12 shares of the stock in a transaction dated Wednesday, August 12th. The shares were bought at an average cost of GBX 2,193 per share, for a total transaction of £263.16. Also, insider Liam Condon bought 14 shares of the company’s stock in a transaction on Friday, July 10th. The stock was bought at an average price of GBX 1,909 per share, for a total transaction of £267.26. In the last 90 days, insiders bought 90 shares of company stock worth $178,458. Insiders own 0.74% of the company’s stock.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Stories
- Five stocks we like better than Johnson Matthey
- AI Token Costs Are Changing the Hardware vs. Software Debate
- 3 ETFs That Could Move as Rate Expectations Shift
- 3 Stocks With September Catalysts Investors Shouldn’t Ignore
- Ollie’s Bargain Outlet Stock Falls on Weak Comps Despite Margin Gains
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
